CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 248.62% | -76.73% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 248.62% | -76.73% | |
| Cost of Revenue | -- | -- | -56.94% | -42.65% | |
| Gross Profit | -- | -- | 202.84% | -85.69% | |
| SG&A Expenses | -- | -- | -12.48% | -6.51% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -17.54% | -10.05% | |
| Operating Income | -- | -- | 27.51% | -75.08% | |
| Income Before Tax | -- | -- | 25.57% | -84.90% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | 25.57% | -84.90% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | 25.57% | -84.90% | |
| EBIT | -- | -- | 27.51% | -75.08% | |
| EBITDA | -- | -- | 28.52% | -87.92% | |
| EPS Basic | -- | -- | 26.22% | -85.85% | |
| Normalized Basic EPS | -- | -- | 20.04% | -824.77% | |
| EPS Diluted | -- | -- | 26.22% | -81.17% | |
| Normalized Diluted EPS | -- | -- | 20.04% | -984.21% | |
| Average Basic Shares Outstanding | -- | -- | 0.88% | 0.22% | |
| Average Diluted Shares Outstanding | -- | -- | 0.88% | -0.66% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |